Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

Neil D. Gross, Julie E. Bauman, William E. Gooding, William Denq, Sufi M. Thomas, Lin Wang, Simion Chiosea, Brian L. Hood, Melanie Flint, Mai Sun, Thomas P. Conrads, Robert L. Ferris, Jonas T. Johnson, Kim Seungwon, Athanassios Argiris, Lori Wirth, Marina N. Nikiforova, Siegfried Jill M., Grandis Jennifer R.